SLC7A5 and neoplasm: It’s conceivable that in a future tumor board meeting, alongside discussing a patient’s tumor mutation status, the doctors will also discuss the tumor’s metabolic profile—and prescribe a drug like a LAT1 inhibitor or a special diet as part of the treatment plan.